本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.73
-0.2650-1.06%
成交量:37.18万
成交额:922.42万
市值:27.78亿
市盈率:-14.52
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:32.76
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.45
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.58
市盈率(LYR):-15.43

数据加载中...

2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/16

重要事件披露

Form 8-K - Current report
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities